Last updated on July 2020

Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors


Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.